On the contrary, several studies have reported that although continuous intravenous insulin infusion improves blood glucose levels more rapidly in critically ill patients [20], it is also associated with an increased risk of hypoglycemia and greater glycemic variability [20,21]. The gene discussed is INS; the disease is Hypoglycemia.